Sphera Funds Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Sell |
|
|||||
|
2025
Q1 | $20.4M | Buy |
|
|||||
|
2024
Q4 | $18.3M | Buy |
|
|||||
|
2024
Q3 | $19.9M | Buy |
|
|||||
|
2024
Q2 | $16.9M | Buy |
|
|||||
|
2024
Q1 | $19.3M | Buy |
|
|||||
|
2023
Q4 | $16.7M | Sell |
|
|||||
|
2023
Q3 | $11.2M | Buy |
|
|||||
|
2023
Q2 | $15.1M | Buy |
|
|||||
|
2023
Q1 | $14.4M | Sell |
|
|||||
|
2022
Q4 | $18.1M | Sell |
|
|||||
|
2022
Q3 | $19.8M | Sell |
|
|||||
|
2022
Q2 | $21.9M | Sell |
|
|||||
|
2022
Q1 | $22.2M | Buy |
|
|||||
|
2021
Q4 | $25.8M | Buy |
|
|||||
|
2021
Q3 | $14.3M | Buy |
|
|||||
|
2021
Q2 | $9.39M | Sell |
|
|||||
|
2021
Q1 | $14.3M | Sell |
|
|||||
|
2020
Q4 | $16.6M | Buy |
|
|||||
|
2020
Q3 | $7.53M | Buy |
|
|||||
|
2020
Q2 | $3.26M | Buy |
|
|||||
|
2020
Q1 | $747K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $4.25M | Buy |
|
|||||
|
2017
Q4 | $2.18M | Hold |
|
|||||
|
2017
Q3 | $2.91M | Sell |
|
|||||
|
2017
Q2 | $4.14M | Buy |
|
|||||
|
2017
Q1 | $2.28M | Hold |
|
|||||
|
2016
Q4 | $1.19M | Hold |
|
|||||
|
2016
Q3 | $2.52M | Buy |
|